Plus Therapeutics Inc
Change company Symbol lookup
Select an option...
PSTV Plus Therapeutics Inc
CSCO Cisco Systems Inc
CVX Chevron Corp
RF Regions Financial Corp
THG Hanover Insurance Group Inc
USB U.S. Bancorp
WFC Wells Fargo & Co
BAC Bank of America Corp
AAPL Apple Inc
ORGO Organogenesis Holdings Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Plus Therapeutics, Inc., formerly Cytori Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on developing treatments for patients battling cancer. The Company provides nanotechnology platform to reformulate and improve workhorse chemotherapeutics to provide benefits to patients and healthcare providers. The Company is focused on developing generic oncology drugs that address unmet medical and market needs. The Company’s lead product candidate, DocePLUS, is an albumin-stabilized PEGylated liposomal formulation of docetaxel. DocePLUS is developed for the treatment of patients with small cell lung cancer (SCLC). The Company is also developing DoxoPLUS, which is a generic PEGylated liposomal formulation of doxorubicin. DoxoPLUS is developed for the treatment of breast cancer, ovarian cancer, multiple myeloma and Kaposi’s sarcoma.

Postmarket

Last Trade
Delayed
$2.70
-0.07 (-2.53%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.77
Day's Change
0.02 (0.73%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
2.87
Day's Low
2.73
Volume
(Light)
Volume:
116,587

10-day average volume:
3,759,586
116,587
  • Prev Close
    2.75
  • Today's Open
    2.76
  • Day's Range
    2.73-2.87
  • Avg Vol (10-day)
    3.8M
  • Last (time)
    3:59p ET 09/22/20
  • Last (size)
    20
  • 52-Wk Range
    0.931 - 16.00
    LowHigh
  • (09/23/19 - 03/12/20)
    197.53%
  • 131.6%
  • Market Cap
    11.8M
  • Shares Outstanding
    4.3M
  • -0.53
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.4
  • 10.44
  • (% of float 08/31/20)
    6.89

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.